---

2013

ルーム内検索
全35件   1  2 次の20件>>
ID
トピック名
閲覧/投稿
最新投稿
作成
122 【レビュー】Smoldering multiple myeloma requiring treatment: time for a new definition? 475 / 0
2013-12-26
KMF CRC
121 【基礎研究】Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile 526 / 0
2013-12-26
KMF CRC
120 【基礎研究】CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma 490 / 0
2013-12-26
KMF CRC
113 【臨床研究】Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma 741 / 0
2013-11-04
KMF CRC
112 【臨床研究】The impact of response on bone-directed therapy in patients with multiple myeloma 578 / 0
2013-11-04
KMF CRC
111 【臨床研究】Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study 653 / 0
2013-11-04
KMF CRC
110 【臨床研究】PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma 582 / 0
2013-11-04
KMF CRC
107 【臨床研究】Implications of continued response after autologous stem cell transplantation for multiple myeloma. 528 / 0
2013-10-03
KMF CRC
106 【基礎研究】Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation 549 / 0
2013-10-03
KMF CRC
103 【基礎研究】RARα2 expression confers myeloma stem cell features 553 / 0
2013-08-29
KMF CRC
102 【臨床研究】Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results 560 / 0
2013-08-29
KMF CRC
101 【基礎研究】Intracellular NAD+ depletion enhances bortezomib-induced anti-myeloma activity 576 / 0
2013-08-29
KMF CRC
100 【基礎研究】Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma 521 / 0
2013-08-29
KMF CRC
96 【レビュー】Pursuing the curative blueprint for early myeloma 554 / 0
2013-07-29
KMF CRC
95 【基礎研究】Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma 533 / 0
2013-07-29
KMF CRC
93 【臨床研究】Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study 666 / 0
2013-07-02
KMF CRC
92 【臨床研究】Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma. 555 / 0
2013-07-02
KMF CRC
91 【臨床研究】Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial 589 / 0
2013-07-02
KMF CRC
88 【基礎研究】MYD88 L265P mutation in Waldenstrom macroglobulinemia 665 / 0
2013-06-05
KMF CRC
87 【基礎研究】Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6 560 / 0
2013-06-05
KMF CRC
全35件   1  2 次の20件>>